Skip to main content

Table 5 Exclusion criteria

From: Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study

An abnormal resting electrocardiogram including atrial fibrillation, bundle brunch aberration or other conduction disturbance
Pre-existing significant left ventricular systolic dysfunction (ejection fraction <40%)
Pre-existing ischaemic or non-ischaemic cardiomyopathy
Pre-existing haemodynamically significant valvular heart disease
Inability to safely negotiate an exercise treadmill
Patients with Type 1 diabetes mellitus
Patients with Type 2 diabetes mellitus taking oral and/or subcutaneous anti-diabetic therapy
Patients with a personal or family history of medullary thyroid carcinoma
Patients with Multiple Endocrine Neoplasia syndrome type 2
Patients with acute renal failure or deteriorating renal function